| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/0471141755.PH1431S67 |
| P698 | PubMed publication ID | 25446288 |
| P50 | author | Mathias Heikenwalder | Q43369827 |
| P2093 | author name string | Achim Weber | |
| Marc Ringelhan | |||
| Detian Yuan | |||
| Florian Reisinger | |||
| P2860 | cites work | Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus | Q21128797 |
| Global cancer statistics | Q22241238 | ||
| Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon | Q27487518 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| The global health burden of infection-associated cancers in the year 2002 | Q28290871 | ||
| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
| Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 | ||
| NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
| Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression | Q29615766 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice | Q29620765 | ||
| Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation | Q33737707 | ||
| Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury | Q34056196 | ||
| The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice | Q34085793 | ||
| Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice | Q34117033 | ||
| Estimating progression to cirrhosis in chronic hepatitis C virus infection. | Q34389608 | ||
| Control of mammary tumor differentiation by SKI-606 (bosutinib) | Q34398204 | ||
| T cell-derived lymphotoxin regulates liver regeneration | Q34698244 | ||
| Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. | Q34765478 | ||
| Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma | Q34958145 | ||
| The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress | Q35105119 | ||
| A lymphotoxin-driven pathway to hepatocellular carcinoma | Q35575883 | ||
| Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. | Q35596851 | ||
| RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma | Q35832116 | ||
| The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma | Q36096454 | ||
| Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges | Q36802501 | ||
| Immunobiology and pathogenesis of viral hepatitis | Q37014739 | ||
| Contradictory functions of NF-kappaB in liver physiology and cancer | Q37163660 | ||
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Q37284612 | ||
| Experimental mouse models for hepatocellular carcinoma research | Q37574072 | ||
| Mouse models of hepatocellular carcinoma | Q37696404 | ||
| Control of hepatitis B virus at the level of transcription. | Q37764967 | ||
| The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development | Q37770209 | ||
| Living in the liver: hepatic infections | Q37987860 | ||
| Medical therapies for hepatocellular carcinoma: a critical view of the evidence | Q38059437 | ||
| Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development | Q38116735 | ||
| What is the role of positron emission tomography in osteonecrosis of the jaws? | Q38146030 | ||
| Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning. | Q38176242 | ||
| Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design | Q38192888 | ||
| Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications | Q38209758 | ||
| Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. | Q38356462 | ||
| Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets | Q38400913 | ||
| Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein | Q38527672 | ||
| Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor | Q39051196 | ||
| Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology | Q39297282 | ||
| Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. | Q40004593 | ||
| Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus | Q40588817 | ||
| Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer | Q40735241 | ||
| Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis | Q41939991 | ||
| The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice | Q42651224 | ||
| Expression of hepatitis C virus envelope proteins in transgenic mice | Q42979163 | ||
| Transgenic expression of hepatitis C virus structural proteins in the mouse | Q42982094 | ||
| Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis | Q42990870 | ||
| Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis | Q43038485 | ||
| Animal models for hepatitis C and related liver disease | Q43161781 | ||
| Chimeric mouse model of hepatitis B virus infection | Q45364557 | ||
| Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene | Q45770734 | ||
| HBx gene of hepatitis B virus induces liver cancer in transgenic mice | Q45852802 | ||
| Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis | Q45885229 | ||
| Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras | Q46107147 | ||
| Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells. | Q46107681 | ||
| IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis | Q46576855 | ||
| A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells | Q50115050 | ||
| A proteomics method revealing disease-related proteins in livers of hepatitis-infected mouse model. | Q51983649 | ||
| TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. | Q53299056 | ||
| Cancer caused by too much apoptosis--an intriguing contradiction? | Q53301813 | ||
| Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC | Q57782566 | ||
| Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma | Q58619568 | ||
| P921 | main subject | liver cancer | Q623031 |
| P304 | page(s) | Unit 14.31.1-17 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Current protocols in pharmacology | Q27722425 |
| P1476 | title | Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammation | |
| P478 | volume | 67 |
| Q30008786 | Prognostic relevance of SAMSN1 expression in gastric cancer | cites work | P2860 |
Search more.